The Clorox Company $CLX Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of The Clorox Company (NYSE:CLX) by 5.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 293,931 shares of the company’s stock after selling 18,124 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Clorox were worth $30,460,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of Clorox during the third quarter worth about $25,000. Darwin Wealth Management LLC purchased a new stake in Clorox during the 2nd quarter valued at approximately $29,000. Caitlin John LLC lifted its position in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after acquiring an additional 253 shares during the period. Root Financial Partners LLC lifted its position in Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after acquiring an additional 145 shares during the period. Finally, Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Trading Down 1.5%

Shares of CLX stock opened at $95.09 on Tuesday. The business’s fifty day moving average price is $94.07 and its 200 day moving average price is $104.10. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03. The firm has a market capitalization of $11.50 billion, a PE ratio of 15.44, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 5.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Wells Fargo & Company dropped their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. Barclays dropped their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. TD Cowen upped their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Finally, Morgan Stanley reduced their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.